143 related articles for article (PubMed ID: 38384180)
1. The Effect of Tegoprazan on the Treatment of Endoscopic Resection-Induced Artificial Ulcers: A Multicenter, Randomized, Active-Controlled Study.
Kim BW; Park JJ; Moon HS; Lee WS; Shim KN; Baik GH; Lim YJ; Lee HL; Youn YH; Park JC; Sung IK; Chung H; Moon JS; Kim GH; Hong SJ; Choi HS
Gut Liver; 2024 Mar; 18(2):257-264. PubMed ID: 38384180
[TBL] [Abstract][Full Text] [Related]
2. Dose-related healing of artificial ulcers after endoscopic submucosal dissection using esomeprazole: A randomized controlled study.
Ko J; Kim SJ; Kang DH; Choi CW; Kim HW; Park SB
Medicine (Baltimore); 2019 May; 98(20):e15701. PubMed ID: 31096515
[TBL] [Abstract][Full Text] [Related]
3. Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: A propensity score-matching analysis.
Maruoka D; Arai M; Kasamatsu S; Ishigami H; Taida T; Okimoto K; Saito K; Matsumura T; Nakagawa T; Katsuno T; Yokosuka O
Dig Endosc; 2017 Jan; 29(1):57-64. PubMed ID: 27492962
[TBL] [Abstract][Full Text] [Related]
4. Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.
Ichida T; Ueyama S; Eto T; Kusano F; Sakai Y
Intern Med; 2019 Jan; 58(2):159-166. PubMed ID: 30210115
[TBL] [Abstract][Full Text] [Related]
5. Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: Prospective randomized controlled trial.
Tsuchiya I; Kato Y; Tanida E; Masui Y; Kato S; Nakajima A; Izumi M
Dig Endosc; 2017 Jul; 29(5):576-583. PubMed ID: 28267236
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia.
Komori H; Ueyama H; Nagahara A; Akazawa Y; Takeda T; Matsumoto K; Matsumoto K; Asaoka D; Hojo M; Yao T; Watanabe S
J Int Med Res; 2019 Apr; 47(4):1441-1452. PubMed ID: 30816056
[TBL] [Abstract][Full Text] [Related]
7. Percent reduction of the ulcer size at 4 weeks is a predictor of the complete healing of endoscopic submucosal dissection-induced gastric ulcers.
Uchida E; Kato S; Tsuchiya I; Ohkuma K; Taniguchi L; Tanida E; Masui Y; Yoshizawa K; Nakajima A; Izumi M
Arab J Gastroenterol; 2020 Sep; 21(3):183-188. PubMed ID: 32798188
[TBL] [Abstract][Full Text] [Related]
8. Effects of Tegoprazan, a Novel Potassium-Competitive Acid Blocker, on Rat Models of Gastric Acid-Related Disease.
Kim DK; Lee KH; Kim SJ; Kim SJ; Lee SJ; Park CH; Kim BT; Song GS; Moon BS; Ryu SY
J Pharmacol Exp Ther; 2019 Jun; 369(3):318-327. PubMed ID: 30894456
[TBL] [Abstract][Full Text] [Related]
9. Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis.
Lee KJ; Son BK; Kim GH; Jung HK; Jung HY; Chung IK; Sung IK; Kim JI; Kim JH; Lee JS; Kwon JG; Park JH; Huh KC; Park KS; Park MI; Kim N; Lee OY; Jee SR; Lee SK; Youn SJ; Kim SK; Lee ST; Hong SJ; Choi SC; Kim TN; Youn YH; Park HJ; Kang MJ; Park CH; Kim BT; Youn S; Song GS; Rhee PL
Aliment Pharmacol Ther; 2019 Apr; 49(7):864-872. PubMed ID: 30843245
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Delayed Ulcer Healing after Endoscopic Submucosal Dissection of Gastric Neoplasms.
Shimozato A; Sasaki M; Ogasawara N; Funaki Y; Ebi M; Tamura Y; Izawa S; Hijikata Y; Yamaguchi Y; Kasugai K
J Gastrointestin Liver Dis; 2017 Dec; 26(4):363-368. PubMed ID: 29253050
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial: tegoprazan, a novel potassium-competitive acid blocker, or lansoprazole in the treatment of gastric ulcer.
Cho YK; Choi MG; Choi SC; Lee KM; Kim TO; Park SH; Moon JS; Lim YJ; Kang DH; Cheon GJ; Baik GH; Kim KO; Cho KB; Jang JS; Park JJ; Son BK; Jung HK; Kim BW; Kim SK; Lee ST; Cha JM; Kim AR; Kim EJ; Park HW; Song GS
Aliment Pharmacol Ther; 2020 Sep; 52(5):789-797. PubMed ID: 32701188
[TBL] [Abstract][Full Text] [Related]
12. Vonoprazan versus proton pump inhibitors for the management of gastric endoscopic submucosal dissection-induced artificial ulcer: A systematic review with meta-analysis.
Kang H; Kim BJ; Choi G; Kim JG
Medicine (Baltimore); 2019 Jun; 98(24):e15860. PubMed ID: 31192917
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes of Vonoprazan-Treated Patients after Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Multicenter Observation Study.
Ishida T; Dohi O; Yamada S; Yasuda T; Yamada N; Tomie A; Tsuji T; Horii Y; Majima A; Horie R; Fukui A; Zen K; Tomatsuri N; Yagi N; Naito Y; Itoh Y
Digestion; 2021; 102(3):386-396. PubMed ID: 32585678
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Effects of Vonoprazan and Lansoprazole for Treating Endoscopic Submucosal Dissection-Induced Artificial Ulcers.
Hirai A; Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Tominaga K; Tokioka S; Higuchi K
Dig Dis Sci; 2018 Apr; 63(4):974-981. PubMed ID: 29464587
[TBL] [Abstract][Full Text] [Related]
15. Two-week treatment with proton pump inhibitor is sufficient for healing post endoscopic submucosal dissection ulcers.
Arai M; Matsumura T; Okimoto K; Oyamada A; Saito K; Minemura S; Maruoka D; Tanaka T; Nakagawa T; Katsuno T; Yokosuka O
World J Gastroenterol; 2014 Nov; 20(43):16318-22. PubMed ID: 25473190
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers.
Jung DH; Park JC; Lee YC; Lee SK; Shin SK; Chung H; Park JJ; Kim JH; Youn YH; Park H
J Clin Gastroenterol; 2021 Mar; 55(3):233-238. PubMed ID: 32341237
[TBL] [Abstract][Full Text] [Related]
17. The effect of early Helicobacter pylori eradication on the healing of ESD-induced artificial ulcers: A retrospective study.
Song WC; Wang XF; Lv WW; Xu XY; Tian M
Medicine (Baltimore); 2019 May; 98(22):e15807. PubMed ID: 31145312
[TBL] [Abstract][Full Text] [Related]
18. Effect of ilaprazole on the healing of endoscopic submucosal dissection-induced gastric ulcer: randomized-controlled, multicenter study.
Bang CS; Shin WG; Seo SI; Choi MH; Jang HJ; Park SW; Kae SH; Yang YJ; Shin SP; Baik GH; Kim HY
Surg Endosc; 2019 May; 33(5):1376-1385. PubMed ID: 30167954
[TBL] [Abstract][Full Text] [Related]
19. Comparison of vonoprazan and proton pump inhibitors for the treatment of gastric endoscopic submucosal dissection-induced ulcer: an updated systematic review and meta-analysis.
Chen L; Jiang D; Hu D; Cui X
BMC Gastroenterol; 2024 Mar; 24(1):110. PubMed ID: 38491413
[TBL] [Abstract][Full Text] [Related]
20. Effects of esomeprazole on the healing process of post-endoscopic submucosal dissection gastric ulcers: a single arm, prospective trial.
Ichida T; Kusano F; Sakai Y
J Rural Med; 2016; 11(2):41-45. PubMed ID: 27928455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
